DIA Biosimilars 2013

PFC Pharma Focus

Clinipace acquires PFC Pharma Focus

Monday, May 23, 2011 08:47 AM

While industry news has been dominated by medium to large CRO acquisitions, consolidation is taking place in the smaller end of the market, too. Last Wednesday morning, CRO Clinipace Worldwide announced it has acquired Swiss CRO PFC Pharma Focus.

More... »

Cenduit: Now with Patient Reminders

CRO Clinipace Worldwide acquires PFC Pharma Focus

Wednesday, May 18, 2011 05:01 AM

Recent industry news has been dominated by stories of medium to large CROs acquiring one another or being acquired by investment companies. But consolidation is taking place in the smaller end of the market, too. This morning, CRO Clinipace Worldwide announced it has acquired Swiss CRO PFC Pharma Focus.

More... »

CRF Health – eCOA Forum

Excel Life Sciences and PFC Pharma Focus Open CRO in India

Monday, June 29, 2009 07:00 AM

Indian site management organization Excel Life Sciences (ELS) and Swiss contract research organization (CRO) PFC Pharma Focus (PFC) have formed an exclusive partnership to launch a new CRO in India.

More... »

CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs